Terrific post 2Relax, in my opinion, except for the text concerning a CEO search.
As medical devices go, BIEL stands alone in the pain space with its suite of pain relieving products. My take is that a deal with a major player in the pain space will provide the deep pockets, marketing, sales, inventory and logistics horsepower BIEL needs to initiate the U.S. launch, not if, but when . . . .